{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:00:57Z","timestamp":1793952057548,"version":"4.8.0"},"reference-count":80,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2016,4,20]],"date-time":"2016-04-20T00:00:00Z","timestamp":1461110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Intern Med"],"published-print":{"date-parts":[[2016,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The management of patients with idiopathic inflammatory myopathy (<jats:styled-content style=\"fixed-case\">IIM<\/jats:styled-content>) remains a challenge given the systemic features beyond active myositis. That is, recognizing the inflammatory arthropathy, varying dermatomyositis rashes, and overt and occult features of interstitial lung disease in addition to myositis adds to the complexity of diagnosis and treatment of <jats:styled-content style=\"fixed-case\">IIM<\/jats:styled-content>. However, clinicians now have available many more immunosuppressive drugs as well as biologic agents for use in patients with myositis and other autoimmune diseases. Here, the use of these agents is reviewed and support based on available published literature is provided even though many studies have been small and results somewhat anecdotal. Glucocorticoids remain the initial treatment of choice in most instances and methotrexate and azathioprine are often used early in the treatment course. These agents are followed by other immunosuppressive drugs, for example mycophenolate mofetil, tacrolimus, cyclosporine and cyclophosphamide, some of which are used alone while combinations of these agents also provide an effective option. There is more rationale for the use of biologic agents such as rituximab from a mechanistic perspective and, given the incorporation of validated core set measures in assessing myositis patients, we can look forward to better designed clinical trials in the future.<\/jats:p>","DOI":"10.1111\/joim.12511","type":"journal-article","created":{"date-parts":[[2016,4,21]],"date-time":"2016-04-21T09:01:57Z","timestamp":1461229317000},"page":"63-74","source":"Crossref","is-referenced-by-count":48,"title":["Update on the pharmacological treatment of adult myositis"],"prefix":"10.1111","volume":"280","author":[{"given":"C. V.","family":"Oddis","sequence":"first","affiliation":[{"name":"Myositis Center Division of Rheumatology and Clinical Immunology University of Pittsburgh School of Medicine Pittsburgh PA USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,4,20]]},"reference":[{"key":"e_1_2_13_2_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.37754"},{"key":"e_1_2_13_3_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-92-3-365"},{"key":"e_1_2_13_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199312303292704"},{"key":"e_1_2_13_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.22477"},{"key":"e_1_2_13_6_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20532"},{"key":"e_1_2_13_7_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21291"},{"key":"e_1_2_13_8_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg403"},{"key":"e_1_2_13_9_1","article-title":"A Consensus Hybrid Definition using a Conjoint Analysis is Proposed as Response Criteria for Minimal and Moderate Improvement in Adult Polymyositis and Dermatomyositis Clinical Trials","volume":"10","author":"Aggarwal R","year":"2014","journal-title":"Arthritis Rheum"},{"key":"e_1_2_13_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(93)90148-I"},{"key":"e_1_2_13_11_1","doi-asserted-by":"publisher","DOI":"10.1100\/tsw.2010.173"},{"key":"e_1_2_13_12_1","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S33110"},{"key":"e_1_2_13_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/00124743-199504000-00007"},{"key":"e_1_2_13_14_1","unstructured":"http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00651040?term=methotrexate+myositis&rank=1"},{"issue":"01","key":"e_1_2_13_15_1","first-page":"S53","article-title":"Randomised double blind controlled trial of methotrexate and steroids compared with azathioprine and steroids in the treatment of idiopathic inflammatory myopathy","volume":"199","author":"Miller J","year":"2002","journal-title":"J Neurol Sci"},{"key":"e_1_2_13_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780240107"},{"key":"e_1_2_13_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10794"},{"key":"e_1_2_13_18_1","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.7.2103110"},{"key":"e_1_2_13_19_1","doi-asserted-by":"publisher","DOI":"10.1186\/ar3704"},{"key":"e_1_2_13_20_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1840-0"},{"key":"e_1_2_13_21_1","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X"},{"key":"e_1_2_13_22_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel336"},{"key":"e_1_2_13_23_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000208416.32471.c0"},{"key":"e_1_2_13_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh499"},{"key":"e_1_2_13_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10026"},{"key":"e_1_2_13_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2009.04.003"},{"key":"e_1_2_13_27_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.142.1.65"},{"key":"e_1_2_13_28_1","first-page":"1542","article-title":"Mycophenolate mofetil in the treatment of severe skin manifestations of dermatomyositis: a series of 4 cases","volume":"27","author":"Gelber AC","year":"2000","journal-title":"J Rheumatol"},{"key":"e_1_2_13_29_1","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0b013e31818d094b"},{"key":"e_1_2_13_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0012-3692(15)50949-5"},{"key":"e_1_2_13_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20212"},{"key":"e_1_2_13_32_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.121043"},{"key":"e_1_2_13_33_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-001-0146-y"},{"key":"e_1_2_13_34_1","doi-asserted-by":"publisher","DOI":"10.3109\/s10165-008-0090-8"},{"key":"e_1_2_13_35_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-011-1713-6"},{"key":"e_1_2_13_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(99)01927-3"},{"key":"e_1_2_13_37_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.21240"},{"key":"e_1_2_13_38_1","first-page":"188","article-title":"The effects of FK506 on refractory inflammatory myopathies","volume":"111","author":"Mitsui T","year":"2011","journal-title":"Acta Neurol Belg"},{"key":"e_1_2_13_39_1","first-page":"436","article-title":"Calcineurin inhibitors in a cohort of patients with antisynthetase\u2010associated interstitial lung disease","volume":"31","author":"Labirua\u2010Iturburu A","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_13_40_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kel112"},{"key":"e_1_2_13_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kev004"},{"key":"e_1_2_13_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.10053"},{"key":"e_1_2_13_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2010.09.004"},{"key":"e_1_2_13_44_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e31824de293"},{"key":"e_1_2_13_45_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20325"},{"key":"e_1_2_13_46_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20464"},{"key":"e_1_2_13_47_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20849"},{"key":"e_1_2_13_48_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker088"},{"key":"e_1_2_13_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.20219"},{"key":"e_1_2_13_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.6.763"},{"key":"e_1_2_13_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.38270"},{"key":"e_1_2_13_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/resp.12214"},{"key":"e_1_2_13_53_1","first-page":"1802","article-title":"Use of etanercept in the treatment of dermatomyositis: a case series","volume":"33","author":"Iannone F","year":"2006","journal-title":"J Rheumatol"},{"key":"e_1_2_13_54_1","doi-asserted-by":"publisher","DOI":"10.1159\/000070852"},{"key":"e_1_2_13_55_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh285"},{"key":"e_1_2_13_56_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh539"},{"key":"e_1_2_13_57_1","doi-asserted-by":"publisher","DOI":"10.1159\/000079547"},{"key":"e_1_2_13_58_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.048744"},{"key":"e_1_2_13_59_1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2007.077974"},{"key":"e_1_2_13_60_1","first-page":"192","article-title":"Anti\u2010tumor necrosis factor inhibitor therapy\u2010induced dermatomyositis and fasciitis","volume":"39","author":"Riolo G","year":"2012","journal-title":"J Rheumatol"},{"key":"e_1_2_13_61_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.142"},{"key":"e_1_2_13_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-009-1370-1"},{"key":"e_1_2_13_63_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091413"},{"key":"e_1_2_13_64_1","doi-asserted-by":"publisher","DOI":"10.2119\/2006-00085.Baechler"},{"key":"e_1_2_13_65_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202794"},{"key":"e_1_2_13_66_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24936"},{"key":"e_1_2_13_67_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ker152"},{"key":"e_1_2_13_68_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu234"},{"key":"e_1_2_13_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65141-3"},{"key":"e_1_2_13_70_1","doi-asserted-by":"publisher","DOI":"10.1006\/clim.1999.4743"},{"key":"e_1_2_13_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2011.03.022"},{"key":"e_1_2_13_72_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2011.11.057"},{"key":"e_1_2_13_73_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket251"},{"key":"e_1_2_13_74_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-014-2507-4"},{"key":"e_1_2_13_75_1","first-page":"2080","article-title":"Alemtuzumab (Campath\u20101H) for treatment of refractory polymyositis","volume":"35","author":"Thompson B","year":"2008","journal-title":"J Rheumatol"},{"key":"e_1_2_13_76_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.30156"},{"key":"e_1_2_13_77_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.24541"},{"key":"e_1_2_13_78_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.34673"},{"key":"e_1_2_13_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.09.016"},{"key":"e_1_2_13_80_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21992"},{"key":"e_1_2_13_81_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22728"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjoim.12511","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjoim.12511","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.12511","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T08:56:12Z","timestamp":1696150572000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/joim.12511"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,20]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["10.1111\/joim.12511"],"URL":"https:\/\/doi.org\/10.1111\/joim.12511","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,20]]}}}